This article is about Maiden Pharmaceuticals Ltd., the company that produced the cough syrups believed to have been linked to the death of nearly 70 Gambian children, announcing on Friday that it is planning to resume the production of its four oral liquid solutions in the near future after health authorities in India concluded that the drugs sent to Gambia were safe and complied with the Indian standards.